Spatially patterned neutralizing icosahedral DNA nanocage for efficient SARS-CoV-2 blocking

27 January 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

New neutralizing strategies against SARS-CoV-2 and associated variants are urgently needed for the treatment of COVID-19. Targeting the SARS-CoV-2 multi-spike trimers, an icosahedral DNA framework was assembled to spatially arrange up to thirty neutralizing aptamers (IDNA-30) with nanometer precision to inhibit viral infection. Each triangular plane of IDNA-30 is composed of three precisely positioned aptamers topologically matching SARS-CoV-2 spike trimer, thus forming a multivalent spatially patterned binding. Additionally, due to its multiple binding sites and moderate size, multifaced IDNA induces aggregation of viruses. Moreover, the rigid icosahedron framework afforded by four-helixes not only forms a steric barrier to prevent the virus from binding to host, but also limits the conformational transformation of SARS-CoV-2 spike trimer. Combining multivalent topologically patterned aptamers with structurally well-defined nano-formulations, IDNA-30 exhibits excellent neutralization against SARS-CoV-2 and a broad neutralizing activity against several mutant strains. Overall, this spatially matched neutralizing strategy provides a new direction for the assembly of neutralizing reagents to enhance the inhibitory effect of SARS-CoV-2 infection and combat other disease-causing viruses.

Keywords

SARS-CoV-2
Aptamer
DNA Nanotechnology
Neutralization

Supplementary materials

Title
Description
Actions
Title
Spatially patterned neutralizing icosahedral DNA nanocage for efficient SARS-CoV-2 blocking
Description
Supplementary Figures and Tables, References
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.